Vir Biotechnology, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
VIR Nasdaq 2830 www.vir.bio

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Vir Biotechnology, Inc.

Is Vir Biotechnology (NASDAQ:VIR) In A Good Position To Deliver On Growth Plans? - Jun 25th, 2025 7:19 am
Spero Therapeutics And 2 Other Promising Penny Stocks To Watch - May 29th, 2025 6:05 am
Vir Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025 - May 28th, 2025 2:05 pm
Vir Biotechnology to Participate in TD Cowen 6th Annual Oncology Innovation Summit - May 20th, 2025 2:05 pm
Vir Biotechnology to Participate in Bank of America Securities 2025 Healthcare Conference - May 12th, 2025 2:05 pm
Vir Biotechnology First Quarter 2025 Earnings: Revenues Disappoint - May 10th, 2025 8:15 am
Vir Biotechnology Announces Preliminary 24-Week Post-End of Treatment Data for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B From the MARCH Study - May 9th, 2025 4:00 am
Vir Biotechnology Inc (VIR) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... - May 8th, 2025 1:31 am
Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Lags Revenue Estimates - May 7th, 2025 4:15 pm
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2025 Financial Results - May 7th, 2025 2:05 pm
Vir Biotechnology to Provide Corporate Update and Report First Quarter 2025 Financial Results on May 7, 2025 - Apr 30th, 2025 2:05 pm
Vir Biotechnology to Present Latest Clinical Data in Hepatitis Delta and B Programs at the European Association for the Study of the Liver (EASL) Congress 2025 - Apr 24th, 2025 7:30 am
Vir Biotechnology, Inc. (VIR): Among Stocks Under $10 that Will Triple - Apr 9th, 2025 7:43 am
Vir Biotechnology, Inc. (NASDAQ:VIR) is favoured by institutional owners who hold 53% of the company - Mar 28th, 2025 6:24 am
Vir Biotechnology Enrolls First Patient in Phase 3 ECLIPSE Registrational Program for Chronic Hepatitis Delta - Mar 13th, 2025 6:05 am
Analysts Have Lowered Expectations For Vir Biotechnology, Inc. (NASDAQ:VIR) After Its Latest Results - Mar 1st, 2025 5:24 am
Vir Biotechnology Inc (VIR) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial ... - Feb 27th, 2025 12:24 am
Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Lags Revenue Estimates - Feb 26th, 2025 3:45 pm
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results - Feb 26th, 2025 2:05 pm
Vir Biotechnology to Participate in TD Cowen 45th Annual Health Care Conference - Feb 19th, 2025 2:05 pm